News items related to:
-
Online access: Training course on reducing barriers to medicines in Africa
Making intellectual property issues easier to understand, to increase access to medicines – and you can apply now! An online...
-
Tackling the hepatitis C epidemic in Malaysia
With new, revolutionary, drugs available, why isn’t everyone getting the cure? An estimated 454,000 people are living with hepatitis C...
-
An important step towards affordable TAF in Ukraine
Gilead adds TAF, a drug used in HIV and Hepatitis B treatment, to the Medicines Patent Pool for Ukraine. It...
-
IAS 2017: Closing ceremony exposes Gilead Sciences
Conference funders, Gilead Sciences, named and shamed for its “insatiable greed” Yesterday, the 9th International AIDS Conference on HIV Science...
-
“We want dolutegravir for all, and we want it now.”
Article first published on the Huffington Post here. We’re calling for a compulsory license on a ‘new’ HIV drug to...
-
A victory for ITPC-MENA : Bristol-Myers Squibb extends its voluntary license on atazanavir to Egypt
During the 9th International AIDS Conference (23-26 July 2017), Bristol-Myers Squibb (BMS) and the Medicines Patent Pool (MPP) announced the...
-
HIV activists denounce ViiV for denying 3.5 million people access to optimal treatment
Today, Monday, 24 July 2017, during the 9th International AIDS Conference on HIV Science in Paris (IAS 2017), HIV treatment...
-
Intellectual Property Group opposes a resolution which would restrict access to medicines in Brazil
Our partner in Brazil highlights the facts in a debate full of confusion. Last month, the Working Group on Intellectual...
-
Brazil: Open letter insists that pharmaceuticals’ interests must NOT be prioritized over public health
The Working Group on Intellectual Property responds to what it sees as ‘an attack on the rights of the Brazilian...
-
Victory: Gilead forced to withdraw Truvada® patent application in Argentina
Gilead prevented from obtaining an illegitimate monopoly at the expense of people’s health. Activists in Argentina, including our partner...
-
Ukraine: HIV patients appeal against deadly patent monopoly
Unmerited patents protecting profit not patients – protesting & appealing the decisions so far. 50% of Ukraine’s budget for HIV...
-
Patients and Ministers discuss access to essential medicines in Ukraine
Working together to reform patent law in Ukraine – and new Working Group is founded. Last month (21 April) our...
